Synthesis and Distribution of Drugs of Abuse and Related Compounds
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Who can apply
No Set aside used. NONE
About this opportunity
INTRODUCTION PURSUANT TO FAR Subpart 5.2�Synopses of Proposed Contract Actions, THIS IS A NOTICE OF A PROPOSED CONTRACT ACTION. THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE MODIFICATION UNDER CONTRACT NO. 75N95022D00016 WITH RESEARCH TRIANGLE INSTITUTE. The National Institute on Drug Abuse (NIDA) Division of Therapeutics and Medical Consequences (DTMC) at the National Institutes of Health (NIH) intends to modify the Single Award Indefinite Delivery, Indefinite Quantity (IDIQ) Contract No. 75N95022D00016 �Synthesis and Distribution of Drugs of Abuse and Related Compounds� to increase the Single Award IDIQ maximum by $3,718,289 from $14,004,330 to $17,722,619 during the five (5) year ordering period from June 9, 2022 to June 8, 2027; there are no other changes. The increase to the IDIQ ...